Skip to content

Limb length discrepancy after rotationplasty surgery.

Limb length discrepancy and impact on patient reported outcome measures in individuals with rotationplasty (ROTMAT). - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/10/075970
Enrollment
30
Registered
2024-10-28
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Rotationplasty patients with at least 1 year of follow up. 2. Patients of any age and any sex shall be recruited for functional outcome and gait analyses. 3. Patients who have reached skeletal maturity (physeal fusion seen on plain X-Ray) for primary outcome measure of knee length discrepancy.

Exclusion criteria

Exclusion criteria: 1. Rotationplasty patients with less than 1 year follow up. 2. Those who present with local and/or systemic relapse.

Design outcomes

Primary

MeasureTime frame
Limb length discrepancy as measured by a difference in knee heights on standard of care X- ray (radiographs). Knee height will be measured from ASIS (anterior superior iliac spine) to the center of the talus on a scannogram taken in an upright weight bearing stance with the prosthesis in use and pelvis squared. The normal limb knee length shall be measured from ASIS to the center of the knee joint.Timepoint: Single point assessment after enrollment.

Secondary

MeasureTime frame
1. Patient or Parent reported outcome measure measured as a continuous variable using pTESS (English) / TESS(English/Marathi/Hindi). 2. Gait analyses 3D gait analysis to assess movement characteristics such as joint angular kinematics, kinetics, & spatiotemporal gait parameters using a 12-camera Qualisys® 3D Motion Capture System (Qualisys AB, Götebor, Sweden). 3. Physician reported functional outcome measure as a continuous variable (MSTS, musculoskeletal tumor society scoring system) in all patientsTimepoint: Single point assessment after enrollment.

Countries

India

Contacts

Public ContactDr Prakash Nayak

Tata Memorial Hospital, Mumbai

nayakprakash@gmail.com24177000

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026